Cas no 3091-32-5 (Tricyclohexylchlorotin)
Tricyclohexylchlorotin Chemical and Physical Properties
Names and Identifiers
-
- TRICYCLOHEXYLTIN CHLORIDE
- CHLOROTRICYCLOHEXYLTIN
- chlorotricyclohexyl-stannan
- TRICYCLOHEXYL STANNIC CHLORIDE
- Tricyclohexylolobic chloride
- Tricyclohexyltin chloride,Chlorotricyclohexyltin
- chloro(tricyclohexyl)stannane
- Chlorotricyclohexylstannane
- Stannane,chlorotricyclohexyl-
- Tricyclohexylchlorot
- Tricyclohexylchlorotin
- Stannane,chlorotricyclohexyl
- Tin,chlorotricyclohexyl
- Tricyclohexyltin chloride500μg
- NSC 202692
- AMY18472
- MFCD00003817
- A876072
- NS00046448
- AKOS015915843
- Tin, chlorotricyclohexyl-
- EINECS 221-437-5
- OJVZYIKTLISAIH-UHFFFAOYSA-M
- 4-ACETYLCYCLOHEXYLCHLOROBENZENE
- Tricyclohexyltin chloride, 97%
- FT-0634658
- 3091-32-5
- NSC-202692
- Stannane, chlorotricyclohexyl-
- A50075
- NSC202692
- ?TRICYCLOHEXYLTIN CHLORIDE
- DTXSID5062845
- tricyclohexyl tin chloride
- DTXCID8038279
- DB-047932
-
- MDL： MFCD00003817
- Inchi： 1S/3C6H11.ClH.Sn/c3*1-2-4-6-5-3-1;;/h3*1H,2-6H2;1H;/q;;;;+1/p-1
- InChI Key： OJVZYIKTLISAIH-UHFFFAOYSA-M
- SMILES： [Sn](C1CCCCC1)(C1CCCCC1)(C1CCCCC1)Cl
Computed Properties
- Exact Mass: 404.12900
- Monoisotopic Mass: 404.129
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 0
- Heavy Atom Count: 20
- Rotatable Bond Count: 0
- Complexity: 240
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: nothing
- XLogP3: nothing
- Topological Polar Surface Area: 0A^2
Experimental Properties
- Color/Form: White solid
- Melting Point: 123-125?°C (lit.)
- Boiling Point: >250°C
- Flash Point: >150°C
- Solubility: Insuluble (1.8E-5 g/L) (25 oC),
- Water Partition Coefficient: Soluble in ethanol, ether, toluene and chloroform. Insoluble in water.
- PSA: 0.00000
- LogP: 7.17360
- Solubility: Insoluble in water, soluble in xylene
Tricyclohexylchlorotin Security Information
-
Symbol:
- Signal Word：Warning
- Hazard Statement： H302-H312-H332-H410
- Warning Statement： P273-P280-P501
- Hazardous Material transportation number：UN 3146 6.1 / PGIII
- WGK Germany：3
- Hazard Category Code： 20/21/22-50/53
- Safety Instruction： S26; S28; S61; S60
- RTECS：WH6830000
-
Hazardous Material Identification：
- Risk Phrases：R20/21/22
- HazardClass：6.1(b)
- PackingGroup：III
- TSCA：Yes
- Storage Condition：Sealed in dry,2-8°C
Tricyclohexylchlorotin Customs Data
- HS CODE：2931900090
- Customs Data：
China Customs Code:
2931900090Overview:
2931900090. Other organic-Inorganic compound. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:AB(Customs clearance form for Inbound Goods,Customs clearance form for outbound goods). MFN tariff:6.5%. general tariff:30.0%
Summary:
2931900090. other organo-inorganic compounds. VAT:17.0%. Tax rebate rate:13.0%. Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward). MFN tariff:6.5%. General tariff:30.0%
Tricyclohexylchlorotin Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Chemenu | CM202152-10g |
Chlorotricyclohexylstannane |
3091-32-5 | 95% | 10g |
$299 | 2021-06-15 | |
| Chemenu | CM202152-25g |
Chlorotricyclohexylstannane |
3091-32-5 | 95% | 25g |
$608 | 2021-06-15 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | SA00762-5g |
Chlorotricyclohexylstannane |
3091-32-5 | 95% | 5g |
￥2268.0 | 2024-07-19 | |
| XI GE MA AO DE LI QI （ SHANG HAI ） MAO YI Co., Ltd. | 480827-5G |
Tricyclohexylchlorotin |
3091-32-5 | 95% | 5G |
￥1506.44 | 2022-02-24 | |
| abcr | AB111638-5 g |
Tricyclohexylchlorotin, 90%; . |
3091-32-5 | 90% | 5 g |
€104.50 | 2023-07-20 | |
| BAI LING WEI Technology Co., Ltd. | DRE-C17814000-250mg |
Tricyclohexyltin chloride |
3091-32-5 | 250mg |
￥ 659 | 2022-04-26 | ||
| TRC | T774500-2.5g |
Tricyclohexylchlorotin |
3091-32-5 | 2.5g |
$ 190.00 | 2023-09-05 | ||
| TRC | T774500-5g |
Tricyclohexylchlorotin |
3091-32-5 | 5g |
$ 339.00 | 2023-09-05 | ||
| TRC | T774500-10g |
Tricyclohexylchlorotin |
3091-32-5 | 10g |
$ 638.00 | 2023-09-05 | ||
| SHANG HAI YI EN HUA XUE JI SHU Co., Ltd. | R027902-250mg |
Tricyclohexylchlorotin |
3091-32-5 | ，97% | 250mg |
￥446 | 2024-05-24 |
Tricyclohexylchlorotin Suppliers
Audited Supplier
Tricyclohexylchlorotin Related Literature
-
Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
-
Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
-
Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
-
Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
-
Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
Additional information on Tricyclohexylchlorotin
Recent Advances in Tricyclohexylchlorotin (CAS: 3091-32-5) Research: Applications and Mechanisms in Chemical Biology and Medicine
Tricyclohexylchlorotin (CAS: 3091-32-5) is an organotin compound that has garnered significant attention in recent years due to its potential applications in chemical biology and medicinal chemistry. Organotin compounds, characterized by their tin-carbon bonds, have been extensively studied for their diverse biological activities, including antimicrobial, antitumor, and anti-inflammatory properties. Tricyclohexylchlorotin, in particular, has shown promise in various preclinical studies, highlighting its role as a versatile scaffold for drug development and chemical biology probes.
Recent studies have focused on elucidating the molecular mechanisms underlying the biological activities of Tricyclohexylchlorotin. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that Tricyclohexylchlorotin exhibits potent inhibitory effects on certain cancer cell lines by targeting key signaling pathways involved in cell proliferation and apoptosis. The compound's ability to modulate these pathways suggests its potential as a lead compound for the development of novel anticancer agents. Furthermore, its unique chemical structure allows for facile derivatization, enabling the synthesis of analogs with enhanced pharmacological properties.
In addition to its anticancer potential, Tricyclohexylchlorotin has been investigated for its antimicrobial properties. A recent study in the European Journal of Medicinal Chemistry reported that the compound exhibits broad-spectrum activity against both Gram-positive and Gram-negative bacteria, including multidrug-resistant strains. The study attributed this activity to the compound's ability to disrupt bacterial membrane integrity and inhibit essential enzymatic processes. These findings underscore the potential of Tricyclohexylchlorotin as a starting point for the development of new antibiotics to address the growing threat of antimicrobial resistance.
The pharmacokinetic and toxicological profiles of Tricyclohexylchlorotin have also been a subject of recent research. A 2024 study published in Chemical Research in Toxicology evaluated the compound's metabolic stability and toxicity in vitro and in vivo. The results indicated that while Tricyclohexylchlorotin exhibits favorable metabolic stability, its toxicity profile necessitates further optimization to improve its safety for therapeutic applications. Researchers are currently exploring structural modifications to reduce toxicity while retaining or enhancing its biological activity.
Beyond its direct therapeutic applications, Tricyclohexylchlorotin has been employed as a valuable tool in chemical biology. Its ability to selectively interact with biomolecules makes it a useful probe for studying protein-ligand interactions and cellular processes. For instance, a recent study in ACS Chemical Biology utilized Tricyclohexylchlorotin-based probes to investigate the role of specific proteins in neurodegenerative diseases, providing new insights into disease mechanisms and potential therapeutic targets.
In conclusion, Tricyclohexylchlorotin (CAS: 3091-32-5) represents a promising compound with multifaceted applications in chemical biology and medicine. Recent advancements have shed light on its mechanisms of action, therapeutic potential, and limitations, paving the way for future research aimed at optimizing its properties for clinical use. Continued exploration of its derivatives and analogs, coupled with a deeper understanding of its biological interactions, will be crucial for unlocking its full potential in addressing unmet medical needs.
3091-32-5 (Tricyclohexylchlorotin) Related Products
- 2587-76-0(Tri-n-octylchlorotin)
- 140176-10-9(Stannane, chlorotrioctadecyl-)
- 111469-27-3(1,12-Distannabicyclo[10.10.10]dotriacontane, 1,12-dichloro-)
- 40291-71-2(Stannane, butylchlorodicyclohexyl-)
- 89860-58-2(Stannane, chlorodimethyl(1-methylcyclohexyl)-)
- 61726-26-9(Stannane, chlorodiethyloctyl-)
- 5827-57-6(Stannane,chlorotridodecyl-)
- 111495-46-6(1,14-Distannabicyclo[12.12.12]octatriacontane, 1,14-dichloro-)
- 3342-67-4(Stannane,chlorotripentyl-)
- 2791-60-8(Stannane,chlorotrihexyl-)
